Glenvale Packaging offers Yener tooling in UK
Press tools, parts, maintenance kits and storage boxes are all included in the agreement
‘We are able to supply a comprehensive range of tooling designs, which can be fitted to the majority of tablet press machines on the market, all of which benefit from the company’s commitment to maintaining high standards of manufacture and consequent long life performance,’ said Garry Coleman, partner at Glenvale Packaging.
The Yener range comprises single-tip and multi-tip tooling options, together with virtually any bespoke configuration – from round to square, and from triple-radius to heart-shaped. Optional tablet embossing – ideal where reference numbers or logos, for example, need to be added – is also available.
‘We are able to supply not just the press tools, but also parts, maintenance kits and storage boxes, all of which are key elements of the Yener product offer,’ Coleman added.
Yener uses a range of steel, applying processes such as heat treatment to reflect the characteristics of the material being compressed and the duty cycle of the machinery to which the tools will be fitted.
The company also places significant emphasis on its coatings technology, such as chromium nitrite, which helps avoid sticking and provides excellent oxidisation resistance and low friction characteristics.
You may also like
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months